Eye Patch Therapy for Central Serous Retinopathy (CSR)

The Washington University

Status and phase: Completed; Phase 1

Conditions: Central Serous Retinopathy (CSR)

Treatments: Device: Eye Patching

Study type: Interventional

Funder types: Other

Identifiers

NCT02036632

201211016

Details and patient eligibility

About

First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will aid in ameliorating disease severity and disease duration.

Enrollment: 12 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults 18 years of age and older
• Both males and females
• Patients diagnosed with active central serous retinopathy
• Patients who are willing to use an eye patch in the affected eye for 24 hours
• Patients who are able to make the follow up appointments as required by the study

Exclusion criteria

• Individuals under 18 years of age
• Patients with vision less than 20/40 in the unaffected eye.
• Patients who are not able to undergo mfERG testing in a realiable manner.

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

12 participants in 1 patient group

Eye Patching

Other group

Description:

Intervention

Treatment:

Device: Eye Patching